FindTrial
Sign In

CRD007 for the Treatment of Abdominal Aorta Aneurysm (The AORTA Trial)

An International, Multi-centre, Randomised, Stratified, Double-blinded, Placebo-controlled, 4-parallel Group Trial Investigating the Efficacy and Safety of Three Different Dose Levels of CRD007 (The AORTA Trial)

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01354184
Enrollment
Unknown
Registered
2011-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2012-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Aortic Aneurysm

Brief summary

This is an investigation of the efficacy and safety of CRD007 compared to placebo in the treatment of patients with abdominal aortic aneurysm.

Interventions

DRUGCRD007
DRUGCRD007 matching placebo

Sponsors

RSPR Pharma AB
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum

Inclusion criteria

* Infra-renal abdominal aortic aneurysm

Exclusion criteria

* Previous infra-renal aortic surgery * Known diabetes

Countries

Denmark, Sweden, United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026